These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1412770)
21. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
22. Factors related to allograft survival in recipients of the same donor. Cubero JJ; Caravaca F; Garcia MC; Espárrago JF; Sanchez Casado E Transplant Proc; 1999 Sep; 31(6):2301. PubMed ID: 10500587 [No Abstract] [Full Text] [Related]
23. Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus. Tedesco-Silva H; Garcia VD; Contieri FL; De Boni Monteiro de Carvalho D; Noronha IL; Gonçalves RT; de Paula FJ; Abbud-Filho M; Manfro RC; David-Neto E; Alfieri F; Ikehara E; Jiang Q; Tai SS; Medina-Pestana JO Transplant Proc; 2010 Jun; 42(5):1659-66. PubMed ID: 20620495 [TBL] [Abstract][Full Text] [Related]
24. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907 [No Abstract] [Full Text] [Related]
26. Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. Jang HJ; Kim SC; Han DJ Transplant Proc; 2000 Nov; 32(7):1714-5. PubMed ID: 11119904 [No Abstract] [Full Text] [Related]
27. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227 [No Abstract] [Full Text] [Related]
28. Living-unrelated kidney transplantation: a real source in the cyclosporine era. Berloco P; Pretagostini R; Poli L; Rossi M; Caricato M; Alfani D; Cortesini R Transplant Proc; 1993 Dec; 25(6):3085-6. PubMed ID: 8266462 [No Abstract] [Full Text] [Related]
29. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients. Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311 [No Abstract] [Full Text] [Related]
30. A randomized prospective study of cadaver donor pretreatment in renal transplantation. Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886 [TBL] [Abstract][Full Text] [Related]
31. Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients. Wilkie ME; Beer JC; Newman D; Raftery MJ; Marsh FP Transplantation; 1992 Sep; 54(3):565-7. PubMed ID: 1412743 [No Abstract] [Full Text] [Related]
32. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389 [No Abstract] [Full Text] [Related]
33. Impact of cyclosporine dose on renal allograft function in an Asian population. Vathsala A; Lee WT; Lim CH Transplant Proc; 1994 Oct; 26(5):2507-8. PubMed ID: 7940768 [No Abstract] [Full Text] [Related]
34. Early cyclosporine concentration as predictor of graft survival in cadaveric renal transplantation. Salmela K; Kyllönen L Transplant Proc; 2001 Jun; 33(4):2441-3. PubMed ID: 11406202 [No Abstract] [Full Text] [Related]
35. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression. Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323 [No Abstract] [Full Text] [Related]